IPO Preview: Vital Therapies – Seeking Alpha
|
IPO Preview: Vital Therapies
Seeking Alpha VTL’s product candidate, the ELAD System, or ELAD, is a bio-artificial liver therapy that operates outside the body, or extracorporeal, and is designed to allow the patient’s own liver to regenerate to a healthy state, or to stabilize the patient until … IPO Report: Vital Therapies (VTL)Equities.com |
